Silence Therapeutics received designations for its divesiran program from the FDA, leading to stock price movement.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Silence Therapeutics received designations for its divesiran program from the FDA, leading to stock price movement.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Silence Therapeutics
UK business
Nothing else this week.
- FDA